COMMUNIQUÉS West-GlobeNewswire

Liberation Labs is Now Liberation Bioindustries
02/06/2025
New name, new brand better reflects the company’s position as a global, commercial-scale biomanufacturer RICHMOND, Ind., June 02, 2025 (GLOBE NEWSWIRE) -- Liberation Labs has a new name and brand – Liberation [...]
Myriad Genetics Shares New Clinical Data Demonstrating Sensitivity of Precise MRD Across Multiple Cancer Types
02/06/2025
MONSTAR-SCREEN-3 study showed 100% detection of circulating tumor DNA (ctDNA) at baseline timepoint, and 60% of patients testing positive one month after surgery had tumor fractions only detectable via ultra-sensitive [...]
Full Dose-Escalation Data Show Continued High Response Rates and Favorable Safety Profile of ISB 2001, a First-in-Class BCMA × CD38 × CD3 Trispecific Antibody, for the Treatment of Relapsed/Refractory Multiple Myeloma
02/06/2025
TRIgnite-1 study shows an overall response rate (ORR) of 74% across nine dose levels, in heavily pretreated patients with a median of six prior lines of therapy ORR is remarkably high in patients with no prior CAR-T or [...]
Solera Health Unveils Enhanced AI Governance Framework for Responsible and Transparent Use of Artificial Intelligence in Digital Health
02/06/2025
Framework Sets an Industry Benchmark for Client Trust and Ethical AI Use to Ensure Patient Safety and Accountability PHOENIX, June 02, 2025 (GLOBE NEWSWIRE) -- Solera Health , the premier digital health delivery company [...]
Evosep unveils new instrumentation and partnership at ASMS 2025
02/06/2025
BALTIMORE, Md., June 02, 2025 (GLOBE NEWSWIRE) -- Evosep ® , a global leader in proteomics solutions, is proud to announce the launch of the Evosep Eno™, a robust, high-throughput separation tool preparing for next [...]
Cytrellis Strengthens Leadership Team in Support of Accelerated Commercial Growth of ellacor® Platform
02/06/2025
WOBURN, Mass., June 02, 2025 (GLOBE NEWSWIRE) -- Cytrellis Biosystems Inc., a medical technology company specializing in novel aesthetic solutions, today announced the appointment of Karyn Siemasko, Ph.D., as Vice [...]
Alvotech Meets Investors and Presents at the Jefferies Global Healthcare Conference 2025 in New York, NY
02/06/2025
REYKJAVIK, Iceland, June 02, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its [...]
Alvotech Meets Investors and Presents at the Jefferies Global Healthcare Conference 2025 in New York, NY
02/06/2025
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the Jefferies Global Healthcare [...]
The Journal of Clinical Oncology Publishes Five-year Analysis of Amtagvi® (lifileucel) in Patients with Advanced Melanoma
02/06/2025
One-time Amtagvi Treatment Continues to Show Deep, Durable Responses and Meaningful Survival One Third of Responses Remain Ongoing without Subsequent Treatment after Five Years Simultaneous Presentation at ASCO 2025 SAN [...]
MiNK Therapeutics Awarded Prestigious NIAID Grant to Advance Allo-iNKT Cell Therapy for Prevention of GvHD in Stem Cell Transplant Patients
02/06/2025
Non-dilutive NIH funding supports development of MiNK’s allogeneic iNKT platform for immune regulation in high-risk HSCT settings NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a [...]
Wildfire Smoke is Already Suffocating Canada – Here’s How to Save Your Lungs
02/06/2025
As Air Quality Plummets Early in Wildfire Season, Lung Health Foundation Shares Five Essential Tips to Protect Yourself Ahead of Clean Air Day TORONTO, June 02, 2025 (GLOBE NEWSWIRE) -- With wildfire season already [...]
Precede Biosciences Presents ASCO 2025 Data Highlighting the Ability of its Liquid Biopsy Platform to Reveal the Biology Underlying Response and Resistance to ADCs and Radiopharmaceuticals
02/06/2025
Using just 1mL of plasma, the Precede Bio platform identified key molecular pathways linked to response and resistance in patients with metastatic breast and prostate cancer treated with sacituzumab govitecan and 177Lu- [...]
Vantive to Invest More Than $1 Billion in Advancing Kidney Care and Vital Organ Support Through Digitally-Enabled Therapies
02/06/2025
Five-year global investment to fuel R&D and manufacturing expansion, supporting development of new technologies and services designed to improve therapy access, care experience and outcomes for patients Company to [...]
Civitas Networks for Health Opens Registration for 2025 Annual Conference
02/06/2025
Agenda and keynote details now available for the premier annual event advancing health data sharing, health improvement, and interoperability PORTLAND, Maine and SAN DIEGO, June 02, 2025 (GLOBE NEWSWIRE) -- Civitas [...]
4D Path Presents Breakthrough Research Demonstrating That Its Unique Digital Predictive Biomarker Identifies Treatment Responders in a Difficult-To-Treat Breast Cancer Patient Population
02/06/2025
QPORTM platform delivers unprecedented predictive insights for patients with low immune infiltrates—achieving a 66% response rate vs. 25% with conventional methods NEWTON, Mass., June 02, 2025 (GLOBE NEWSWIRE) -- 4D [...]
HOOPP appoints Reena Carter as new Chief Financial Officer
02/06/2025
Ms. Carter brings more than 20 years of financial leadership in Canada’s pension industry TORONTO, June 02, 2025 (GLOBE NEWSWIRE) -- The Healthcare of Ontario Pension Plan (HOOPP) is pleased to announce the appointment [...]
LogicMark, Inc. Common Stock to Commence Trading on OTC Markets as the Company Continues Advancing Growth Initiatives
02/06/2025
LOUISVILLE, Ky., June 02, 2025 (GLOBE NEWSWIRE) -- LogicMark, Inc. (the “Company”), a provider of personal emergency response systems (“PERS”), health communication devices, and technology for the growing care economy, [...]
Syncromune® Inc. Presents Positive Results from SYNC-T® Therapy SV-102 Phase 1 Metastatic Prostate Cancer Trial at ASCO 2025
02/06/2025
Presentation highlights deep and durable responses and radiographic resolution of bone metastases in patients with advanced prostate cancer Final clinical data demonstrate an 87% overall response rate in patients with [...]
Rakovina Therapeutics Announces 2025 Q1 Financial Results and Provides Corporate Update
02/06/2025
All dollar amounts reflected in Canadian dollars unless otherwise stated VANCOUVER, British Columbia, June 02, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“Rakovina” or the “Company”), a [...]

Pages